Catalyst Wire Dossier Catalyst Wire Dossier

ARAZLO

TAZAROTENE · Bausch Health US, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARAZLO, covering 2019-12-18 to 2019-12-18. Get the full timeline:

Most recent: FDA Approved: ARAZLO — Original Application (Bausch Health US, LLC)

See pricing